Combined with image current detection, as in FT-ICR, the orbitrap provides a high-accuracy, high-resolution, simple and compact mass analyzer that is now routinely used in proteomics research ...

Tron Looks to Go Public in the U.S., Form Strategy-Like TRX Holding Firm: FT The new venture will buy and hold TRX, like bitcoin holding firm Strategy.

2 Pilots, 1,500 Lbs. of Cocaine and an International Prison Escape: Inside the Wild True Story of Netflix’s Cocaine Air Former French military pilots Pascal Fauret and Bruno Odos were arrested ...

Nvidia insiders sold over $1 billion worth of company stock in the past year, with a notable uptick in recent trading activity as executives capitalize on surging investor interest in artificial ...

Unilever is paying $1.5 billion (1.09 billion pounds) to buy men's personal care brand Dr Squatch from private-equity firm Summit Partners, the Financial Times reported on Friday, citing sources.

A carjacker who beat a man to death in east Fort Worth pleaded guilty to murder and was sentenced to 28 years in prison. Courtesy: McClatchy Co.

Five people were shot to death on Sunday in Fort Worth at four locations across the city, authorities said. The last of the killings, which occurred over about 20 hours, was a double homicide ...

Moody’s Corporation (NYSE:MCO) announced today that it has fully acquired ICR Chile (ICR), a leading provider of domestic credit ratings in Chile. The transa ...

Combined with a parallel Orbitrap analyser, the Orbitrap Astral mass spectrometer has, in just two years, been delivered to hundreds of laboratories worldwide. Hundreds of studies have ranged from ...

Laurel, the world’s first AI Time platform, today announced it has raised $100 million in Series C funding led by IVP, with participation from GV (Google Ven ...

Thermo Scientific Exactive Plus Mass spectrometer is the ultimate screening machine for confident identification and quantification of compounds in complex samples.

Eli Lilly has struck a deal to buy Crispr gene-editing start-up Verve Therapeutics for up to $1.3bn, the latest acquisition by the world’s most valuable drugmaker as it seeks to boost its ...